Farmingdale, NY · Founded 2014 · Privately Held (backing)
Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases. DepYmed is based in Farmingdale, NY and was founded in 2014. Its last reported valuation was $36.3 million in Apr 2021. It has raised $14.3 million across 6 recorded rounds; the latest was a $250,000 seed round in Apr 2025.
Last reported valuation
$36.3M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Apr 2025
No prints on record
No secondary trades in DepYmed shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DepYmed with a free account
·Watch DepYmed: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of DepYmed stock.
